🟢 99/100

This product looks safe

  • Niacin/Niacinamide: 190mg is 5.4× the Tolerable Upper Intake Level (35mg)
  • Manganese: 20mg is 1.8× the Tolerable Upper Intake Level (11mg)
  • 50% of ingredients have research evidence
D Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin/Niacinamide: 190mg is 5.4× the Tolerable Upper Intake Level (35mg)
⚠️ Manganese: 20mg is 1.8× the Tolerable Upper Intake Level (11mg)

Label Data

7 Tablet(s) Serving Size
14 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A
25000 IU (500% DV)
Vitamin C
1200 mg (2000% DV)
400 IU (100% DV)
✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.01mg UL 0.1mg
400 IU (1333% DV)
📊 17.9× RDA — above typical dose (UL: 1000 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 268.0mg UL 1000mg
70 mcg (88% DV)
✅ Within RDA (0.6× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.07mg
100 mg (6667% DV)
📊 83.3× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 100mg
50 mg (2941% DV)
📊 38.5× RDA — above typical dose 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 50mg
190 mg (950% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 5.4× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 190mg UL 35mg
Vitamin B-6 Complex
100 mg (5000% DV)
800 mcg (200% DV)
✅ 2.0× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.8mg UL 1.0mg
100 mcg (1667% DV)
📊 41.7× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.1mg
300 mcg (100% DV)
📊 10.0× RDA — above typical dose 📚 26 studies (Tier A: 0, B: 11)
RDA 0.03mg This product: 0.3mg
500 mg (5000% DV)
📊 100.0× RDA — above typical dose 📚 1 studies — no high-quality reviews
RDA 5mg This product: 500mg
Calcium
500 mg (50% DV)
200 mcg (133% DV)
✅ 1.3× RDA — within safe limits 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.2mg UL 1.1mg
500 mg (125% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg
25 mg (167% DV)
✅ 2.3× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 25mg UL 40mg
200 mcg (286% DV)
📊 3.6× RDA — above typical dose (UL: 0.4 mg) 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.2mg UL 0.4mg
2 mg (100% DV)
✅ 2.2× RDA — within safe limits 📚 36 studies (Tier A: 0, B: 11)
RDA 0.9mg This product: 2mg UL 10mg
20 mg (1000% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.8× (UL: 11 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 20mg UL 11mg
200 mcg (167% DV)
📊 5.7× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.2mg
100 mcg (133% DV)
✅ 2.2× RDA — within safe limits 📚 2 studies — no high-quality reviews
RDA 0.045mg This product: 0.1mg UL 2mg
Potassium
99 mg (3% DV)
60 mg
✅ Within RDA (0.1× RDA of 550 mg) 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 60mg UL 3500mg
100 mg
📊 Market median: 550.0mg (217 products) 📚 29 studies (Tier A: 0, B: 5)
This product: 100mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 100mg
50 mg
📊 Market median: 500.0mg (9 products)
This product: 50mg
50 mcg
📊 Market median: 0.5mg (6 products) 📚 1 studies (Tier A: 0, B: 1)
This product: 0.05mg UL 1.8mg
1.5 mg
📊 Market median: 3.0mg (58 products) 📚 2 studies — no high-quality reviews
This product: 1.5mg UL 20mg
Trace Elements
100 mcg
L-Cysteine/N-Acetyl-L-Cysteine
200 mg
12.5 mg
📊 Market median: 500.0mg (193 products) 📚 7 studies — no high-quality reviews
This product: 12.5mg
Glutamic Acid
20 mg
114 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 114mg
Pycnogenol(R)
25 mg
📊 Market median: 100.0mg (284 products) 📚 10 studies (Tier A: 0, B: 4)
This product: 50mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 40mg
Eleutherococcus Senticosus
25 mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 25mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 25mg
100 mg
📊 Market median: 500.0mg (497 products) 📚 132 studies (Tier A: 0, B: 40)
This product: 100mg
Green Papaya Extract
100 mg
Beet Extract
50 mg
Apple Pectin
50 mg
50 mg
📊 Market median: 200.0mg (136 products) 📚 3 studies — no high-quality reviews
This product: 50mg
Rose Hips
100 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 100mg
📊 Market median: 500.0mg (19 products)
This product: 25mg
2.4 mg
📊 Market median: 108.0mg (8 products) 📚 9 studies (Tier A: 0, B: 4)
This product: 2.4mg
Hesperidin Complex
10 mg
Special Ultra Preventive(R) Green Base Proprietary Blend
550 mg
Ultra Preventive(R) Green Base

Other Ingredients

Cellulose Vegetable Stearate

Label Claims — Verification

Nutrient
All Other
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, adults take 7 tablets daily or as directed by your healthcare professional. This product is best taken with meals.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

WARNING: This product contains Vitamin K, which interferes with the prescription drugs COumadin(R) and Warfarin. No not take this if taking either of these drugs.

🧪 Formulation Notes

This product contains NO yeast, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.

Ultra Preventive IX With Vitamin K

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Pycnogenol(R) - French maritime bark extract-(TM)

Formula #84551

Product Details

UPC / SKU 3 10539 01931 3
DSLD Entry Date 2012-06-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 10259
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →